About Ovidac
Ovidac 5000iu is a pharmaceutical-grade human chorionic gonadotropin (hCG) preparation extensively investigated in endocrine research applications. This glycoprotein hormone preparation provides researchers with a standardized tool for examining luteinizing hormone receptor signaling pathways and gonadotropin-mediated cellular responses in laboratory settings. The compound’s well-characterized pharmacological profile makes it valuable for studies investigating reproductive endocrinology and hormone receptor interactions. Research scientists at Stroid UK Shop utilize this preparation for comprehensive endocrine pathway analysis.
Laboratory Applications
Researchers investigate Ovidac’s effects on Leydig cell steroidogenesis and luteal function in various experimental models. Studies examine its role in maintaining corpus luteum function and supporting steroidogenic enzyme expression patterns. The compound’s ability to mimic luteinizing hormone activity makes it valuable for post cycle therapy gonadotropin research protocols. Scientists analyze its effects on testosterone biosynthesis pathways and gonadal steroid production in controlled laboratory environments. Research applications extend to investigating hCG’s neuroprotective properties and its interactions with various receptor systems. Comparative studies evaluate its effectiveness alongside other research compounds available in our SARMS collection and peptide research lines.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Human Chorionic Gonadotropin |
| Potency | 5000 International Units |
| CAS Number | 9002-61-3 |
| Molecular Formula | C1105H1770N318O336S26 |
| Molecular Weight | Approximately 36,700 Da |
| Storage | 2-8°C, protect from light |
| Stability | 24 months when stored properly |
| Solubility | Water soluble |
Research Compliance
Ovidac 5000iu is supplied exclusively for in-vitro research purposes and laboratory analytical studies. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols and proper handling procedures when conducting studies with this gonadotropin preparation. All investigational work should be performed in controlled laboratory environments by qualified research personnel.
